KY HB190 | 2024 | Regular Session
Status
Completed Legislative Action
Spectrum: Partisan Bill (Republican 1-0)
Status: Passed on April 18 2024 - 100% progression
Action: 2024-04-18 - signed by Governor (Acts Ch. 213)
Text: Latest bill text (Chaptered) [PDF]
Spectrum: Partisan Bill (Republican 1-0)
Status: Passed on April 18 2024 - 100% progression
Action: 2024-04-18 - signed by Governor (Acts Ch. 213)
Text: Latest bill text (Chaptered) [PDF]
Summary
Amends 2024 Ky. Acts. ch. 104, sec. 3 (2024 RS SB 188/GA, sec. 3) to define “national average drug acquisition cost,” to temporarily exempt retail chain pharmacies from minimum drug reimbursement requirement, and to make technical amendment; EFFECTIVE January 1, 2025.
Title
AN ACT relating to pharmacy benefits.
Sponsors
Rep. Scott Sharp [R] |
Roll Calls
2024-04-15 - Senate - Senate: Third Reading W/scs1 RSN# 3327 (Y: 38 N: 0 NV: 0 Abs: 0) [PASS]
2024-04-15 - Senate - Senate: Third Reading RSN# 3322 (Y: 38 N: 0 NV: 0 Abs: 0) [PASS]
2024-04-15 - House - House: Third Reading RCS# 487 (Y: 92 N: 0 NV: 0 Abs: 8) [PASS]
2024-03-12 - House - House: Third Reading RCS# 270 (Y: 96 N: 0 NV: 0 Abs: 2) [PASS]
2024-04-15 - Senate - Senate: Third Reading RSN# 3322 (Y: 38 N: 0 NV: 0 Abs: 0) [PASS]
2024-04-15 - House - House: Third Reading RCS# 487 (Y: 92 N: 0 NV: 0 Abs: 8) [PASS]
2024-03-12 - House - House: Third Reading RCS# 270 (Y: 96 N: 0 NV: 0 Abs: 2) [PASS]
History
Date | Chamber | Action |
---|---|---|
2024-04-18 | House | signed by Governor (Acts Ch. 213) |
2024-04-15 | House | delivered to Governor |
2024-04-15 | House | enrolled, signed by President of the Senate |
2024-04-15 | House | enrolled, signed by Speaker of the House |
2024-04-15 | House | passed 92-0 |
2024-04-15 | House | House concurred in Senate amendment Committee Substitute (1) |
2024-04-15 | House | posted for passage for concurrence in Senate Committee Substitute (1) |
2024-04-15 | House | to Rules (H) |
2024-04-15 | House | received in House |
2024-04-15 | Senate | 3rd reading, passed 38-0 with Committee Substitute (1) |
2024-04-15 | Senate | posted for passage in the Consent Orders of the Day for Monday, April 15, 2024 |
2024-04-15 | Senate | reported favorably, to Rules with Committee Substitute (1) as a consent bill |
2024-04-12 | Senate | returned to Banking & Insurance (S) |
2024-04-12 | Senate | 2nd reading |
2024-04-12 | Senate | taken from Banking & Insurance (S) |
2024-04-12 | Senate | to Banking & Insurance (S) |
2024-03-28 | Senate | returned to Committee on Committees (S) |
2024-03-28 | Senate | 1st reading |
2024-03-28 | Senate | taken from Committee on Committees (S) |
2024-03-13 | Senate | to Committee on Committees (S) |
2024-03-13 | Senate | received in Senate |
2024-03-12 | House | 3rd reading, passed 96-0 with Committee Substitute (1) |
2024-03-08 | House | posted for passage in the Regular Orders of the Day for Monday, March 11, 2024 |
2024-03-08 | House | 2nd reading, to Rules |
2024-03-07 | House | reported favorably, 1st reading, to Calendar with Committee Substitute (1) |
2024-02-15 | House | to Health Services (H) |
2024-01-08 | House | to Committee on Committees (H) |
2024-01-08 | House | introduced in House |
Subjects
Actuarial Analysis
Drugs and Medicines
Education, Higher
Effective Dates, Delayed
Health Benefit Mandate
Insurance, Health
Local Mandate
Pharmacists
State Employees
Technical Corrections
Drugs and Medicines
Education, Higher
Effective Dates, Delayed
Health Benefit Mandate
Insurance, Health
Local Mandate
Pharmacists
State Employees
Technical Corrections